Beamtree is pleased to announce a new agreement with Abbott, a leading global healthcare company, to distribute Beamtree’s RippleDown products. The new agreement marks a great step forward and a renewed joint approach to advancing automation and value through Beamtree’s core Diagnostics product, RippleDown.
Beamtree’s CEO, Tim Kelsey, said: “I am delighted to announce this expansive opportunity for Beamtree, which further solidifies our international growth and ambition. Beamtree is a pioneer in the automation of human expertise, and this new partnership approach will enable us to bring RippleDown’s industry-leading technology to an expanded global market.”
Read the full statement here.
Share this article
